Measure your business against your peers using our robust analysis of the gene therapy contract development and manufacturing market. Our pricing matrix comprises material cost, infrastructure and development process data from CDMOs all over the world so you can make informed decisions to best position your business.
Comprehensive overview of the gene therapy landscape in 2024, including information on AAV, Lentiviral and non-viral gene therapies. Discover the trends and technologies shaping gene therapy development and manufacturing with exclusive input from innovators, CDMO owners, PhDs and researchers across advanced therapeutics.
